A Study Of Senseera Liquid Biopsy In Detecting ACR
Jacksonville, FL
The purpose of the study is to optimize and validate the performance of the Senseera liquid biopsy cfChIP-seq assay for the detection of Acute Cellular Rejection (ACR) of the liver in patients who underwent a liver graft, as compared to the standard of care biopsy of the liver and histopathological examination by specialized pathologists.
The sensitivity and specificity of the test will be compared to the reference standard, based on the biopsy results, and the overall diagnostic accuracy of the assay will be assessed.